Vasoactive intestinal peptide is a well-characterized hormone with roles in smooth muscle relaxation, immune modulation, and neurotransmission that have been studied since the 1970s — a long, legitimate research history. Its more recent popularity traces to claims connecting it to mold-related illness and chronic fatigue syndromes that sit on much less settled scientific ground.
The Established Physiological Research
VIP’s role in smooth muscle and secretory regulation across the gut, lungs, and other systems is well-documented in the classical endocrinology and neuroscience literature — genuinely foundational research, not a recent or fringe finding.
“The hormone itself is extremely well studied. The specific illness framework that made it popular again is resting on a single clinical source, not a body of independent research.”
— a neuroendocrinology researcher who reviewed both bodies of literature for this pieceWhere the Mold-Illness Connection Comes From
The theory linking VIP deficiency to mold-related chronic illness originates largely from one physician’s clinical framework rather than from a broad, independently replicated body of peer-reviewed research — a single-source theory that has not achieved the kind of independent validation the underlying VIP physiology itself has.
Why That Distinction Matters for Buyers
A compound with decades of legitimate basic-science research behind it can still be attached to newer claims that haven’t gone through the same scrutiny — the foundational research being solid doesn’t validate every downstream claim built on top of it.